NRIX
Price
$27.15
Change
+$0.12 (+0.44%)
Updated
Nov 13 closing price
90 days until earnings call
RXRX
Price
$7.32
Change
-$0.26 (-3.43%)
Updated
Nov 13 closing price
110 days until earnings call
Ad is loading...

NRIX vs RXRX

Header iconNRIX vs RXRX Comparison
Open Charts NRIX vs RXRXBanner chart's image
Nurix Therapeutics
Price$27.15
Change+$0.12 (+0.44%)
Volume$624.55K
CapitalizationN/A
Recursion Pharmaceuticals
Price$7.32
Change-$0.26 (-3.43%)
Volume$6.59M
CapitalizationN/A
NRIX vs RXRX Comparison Chart
Loading...
NRIX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NRIX vs. RXRX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Buy and RXRX is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (NRIX: $27.17 vs. RXRX: $7.31)
Brand notoriety: NRIX and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 75% vs. RXRX: 134%
Market capitalization -- NRIX: $1.92B vs. RXRX: $2.1B
NRIX [@Biotechnology] is valued at $1.92B. RXRX’s [@Biotechnology] market capitalization is $2.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 6 bullish TA indicator(s).

  • NRIX’s TA Score: 6 bullish, 4 bearish.
  • RXRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both NRIX and RXRX are a good buy in the short-term.

Price Growth

NRIX (@Biotechnology) experienced а +0.63% price change this week, while RXRX (@Biotechnology) price change was +4.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

NRIX is expected to report earnings on Feb 12, 2025.

RXRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.1B) has a higher market cap than NRIX($1.93B). NRIX YTD gains are higher at: 163.275 vs. RXRX (-25.862). NRIX has higher annual earnings (EBITDA): -177.82M vs. RXRX (-348.35M). RXRX has more cash in the bank: 474M vs. NRIX (448M). NRIX has less debt than RXRX: NRIX (27.1M) vs RXRX (89.9M). NRIX has higher revenues than RXRX: NRIX (56.4M) vs RXRX (48.6M).
NRIXRXRXNRIX / RXRX
Capitalization1.93B2.1B92%
EBITDA-177.82M-348.35M51%
Gain YTD163.275-25.862-631%
P/E RatioN/AN/A-
Revenue56.4M48.6M116%
Total Cash448M474M95%
Total Debt27.1M89.9M30%
TECHNICAL ANALYSIS
Technical Analysis
NRIXRXRX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
NRIX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEIYX38.280.02
+0.05%
Putnam Large Cap Value Y
PWGIX28.940.01
+0.03%
Impax US Sustainable Economy Instl
OAKWX22.80-0.10
-0.44%
Oakmark Global Select Investor
GLNCX20.66-0.10
-0.48%
MFS Global New Discovery C
PSGRX74.43-0.99
-1.31%
Putnam Small Cap Growth R

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with BEAM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+0.52%
BEAM - NRIX
44%
Loosely correlated
-1.57%
DNLI - NRIX
44%
Loosely correlated
-0.84%
EDIT - NRIX
43%
Loosely correlated
-3.58%
LYEL - NRIX
43%
Loosely correlated
-5.58%
RXRX - NRIX
43%
Loosely correlated
-3.56%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-3.56%
BEAM - RXRX
61%
Loosely correlated
-1.57%
CRSP - RXRX
56%
Loosely correlated
-1.85%
EXAI - RXRX
55%
Loosely correlated
-3.61%
PRME - RXRX
54%
Loosely correlated
-8.33%
NTLA - RXRX
52%
Loosely correlated
-3.24%
More